Effektivität Und Effizienz Von Behandlungspfaden für Patienten Mit Depressiven Erkrankungen: Stepped Care Als Ansatz für Ein Leitliniengerechtes Und Integriertes Versorgungsmanagement
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Depression
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Enrollment
- 737
- Locations
- 1
- Primary Endpoint
- Change in depression severity (PHQ-D-9)
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The main aim of the project is the implementation and evaluation of a stepped care model (SCM) for patients with depression with 6 treatment options of varying intensity and setting, including innovative technologies (e-mental health, telephone-based psychotherapy). Within this complex intervention, patients are treated by a multiprofessional network of health care providers in Hamburg, Germany. The study compares the SCM condition (intervention group) to a control group receiving treatment as usual (cluster randomization on the level of participating general practitioners). It is expected that the SCM condition will show better results regarding reduction of mental symptoms, improvement of quality of life, more efficient access to care and better cost-benefit ratio.
Investigators
PD Dr. phil. Birgit Watzke
Principal Investigator
Universitätsklinikum Hamburg-Eppendorf
Eligibility Criteria
Inclusion Criteria
- •\>4 points on PHQ-D-9 depression scale
- •sufficient knowledge of German language
- •health situation that allows questionnaire completion
Exclusion Criteria
- •insufficient knowledge of German language
- •health situation not allowing questionnaire completion
Outcomes
Primary Outcomes
Change in depression severity (PHQ-D-9)
Time Frame: Baseline, 3 months, 6 months, 12 months
Change in patient-rated depression symptom severity: Patient Health Questionnaire 9, German version (PHQ-D-9; Löwe, Zipfel \& Herzog, 2002)
Secondary Outcomes
- Quality of life (SF-12)(Baseline, 3 months, 6 months, 9 months)
- Health service utilization and medication consumption(Baseline, 6 months, 12 months)
- Self-esteem(Baseline, 3 months, 6 months, 12 months)
- Cost-benefit ratio (QALYs)(Baseline, 6 months, 12 months)
- Response/Remission/Relapse (PHQ-D-9)(Baseline, 3 months, 6 months, 12 months)
- Therapeutic alliance(Baseline, 3 months, 6 months, 12 months)
- Anxiety symptoms (PHQ-D)(Baseline, 3 months, 6 months, 12 months)
- Somatisation (PHQ-D)(Baseline, 3 months, 6 months, 12 months)
- Panic symptoms (PHQ-D)(Baseline, 3 months, 6 months, 12 months)
- Quality of life (EQ-5D)(Baseline, 3 months, 6 months, 12 months)
- General anxiety disorder (GAD-7)(Baseline, 3 months, 6 months, 12 months)